- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Natco Pharma has announced that Dr. Muddasaani Pulla Reddy, Executive Vice President - R&D, and Mr. Ch Srinivas, Senior Vice President – Demand & Supply, are superannuating, and Mr. R. Sridhar Reddy, Senior Vice President – Global Corporate Quality Assurance, has resigned, all effective after business hours on the same date. These senior management changes mark the departure of key leadership in research, supply chain, and quality assurance, which will impact operational continuity. Mr. Reddy has expressed commitment to a smooth transition during his exit.